Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Genocea Biosciences stock | $1.74

Learn how to easily invest in Genocea Biosciences stock.

Genocea Biosciences Inc is a biotechnology business based in the US. Genocea Biosciences shares (GNCA) are listed on the NASDAQ and all prices are listed in US Dollars. Genocea Biosciences employs 72 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Genocea Biosciences

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GNCA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Genocea Biosciences stock price (NASDAQ: GNCA)

Use our graph to track the performance of GNCA stocks over time.

Genocea Biosciences shares at a glance

Information last updated 2021-10-16.
Latest market close$1.74
52-week range$1.65 - $4.05
50-day moving average $1.88
200-day moving average $2.16
Wall St. target price$6.10
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.86

Buy Genocea Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Genocea Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genocea Biosciences price performance over time

Historical closes compared with the close of $1.74 from 2021-10-20

1 week (2021-10-14) 1.74
1 month (2021-09-21) -12.56%
3 months (2021-07-21) -17.54%
6 months (2021-04-21) -23.01%
1 year (2020-10-20) -29.55%
2 years (2019-10-18) -33.33%
3 years (2018-10-19) 140.33%
5 years (2016-10-20) 4.03

Genocea Biosciences financials

Revenue TTM $453,000
Gross profit TTM $1.4 million
Return on assets TTM -52.4%
Return on equity TTM -592.69%
Profit margin 0%
Book value $0.07
Market capitalisation $100.3 million

TTM: trailing 12 months

Shorting Genocea Biosciences shares

There are currently 1.5 million Genocea Biosciences shares held short by investors – that's known as Genocea Biosciences's "short interest". This figure is 1.2% up from 1.5 million last month.

There are a few different ways that this level of interest in shorting Genocea Biosciences shares can be evaluated.

Genocea Biosciences's "short interest ratio" (SIR)

Genocea Biosciences's "short interest ratio" (SIR) is the quantity of Genocea Biosciences shares currently shorted divided by the average quantity of Genocea Biosciences shares traded daily (recently around 263289.36170213). Genocea Biosciences's SIR currently stands at 5.64. In other words for every 100,000 Genocea Biosciences shares traded daily on the market, roughly 5640 shares are currently held short.

However Genocea Biosciences's short interest can also be evaluated against the total number of Genocea Biosciences shares, or, against the total number of tradable Genocea Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genocea Biosciences's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Genocea Biosciences shares in existence, roughly 30 shares are currently held short) or 0.0497% of the tradable shares (for every 100,000 tradable Genocea Biosciences shares, roughly 50 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Genocea Biosciences.

Find out more about how you can short Genocea Biosciences stock.

Genocea Biosciences share dividends

We're not expecting Genocea Biosciences to pay a dividend over the next 12 months.

Have Genocea Biosciences's shares ever split?

Genocea Biosciences's shares were split on a 1:8 basis on 21 May 2019. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Genocea Biosciences shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Genocea Biosciences shares which in turn could have impacted Genocea Biosciences's share price.

Genocea Biosciences share price volatility

Over the last 12 months, Genocea Biosciences's shares have ranged in value from as little as $1.65 up to $4.045. A popular way to gauge a stock's volatility is its "beta".

GNCA.US volatility(beta: 1.53)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genocea Biosciences's is 1.5302. This would suggest that Genocea Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Genocea Biosciences overview

Genocea Biosciences, Inc. , a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy using neoantigen-targeted peripheral cells for ATLAS identified anti-tumor antigens that are used to manufacture peripheral blood-derived tumor-specific T cell therapy; and GEN-009, a neoantigen vaccine candidate, delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. .

Frequently asked questions

What percentage of Genocea Biosciences is owned by insiders or institutions?
Currently 8.463% of Genocea Biosciences shares are held by insiders and 61.2% by institutions.
How many people work for Genocea Biosciences?
Latest data suggests 72 work at Genocea Biosciences.
When does the fiscal year end for Genocea Biosciences?
Genocea Biosciences's fiscal year ends in December.
Where is Genocea Biosciences based?
Genocea Biosciences's address is: 100 Acorn Park Drive, Cambridge, MA, United States, 02140
What is Genocea Biosciences's ISIN number?
Genocea Biosciences's international securities identification number is: US3724274010
What is Genocea Biosciences's CUSIP number?
Genocea Biosciences's Committee on Uniform Securities Identification Procedures number is: 372427104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site